Basal Insulin
Basal Insulin - Related Videos
05:52
Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
0 Views •
Cited by 16 •
2011
Conserved insulin signaling pathways found in the fruit fly Drosophila melanogaster make this organism a potential tool for modeling metabolic disorders including type II diabetes. To this end, it is critical to establish physiological assays to effectively measure systemic insulin action in peripheral glucose disposal in the adult fly.
12:08
Improving IV Insulin Administration in a Community Hospital
0 Views •
Cited by 7 •
2012
When compared to the previous paper protocol, implementation of a computerized glucose management system results in a substantial increase in blood glucose concentration measurements within the target range. Using a computerized glucose management system to monitor blood glucose levels, decreases in severe hypoglycemia (<40 mg/dL), clinical hypoglycemia (<70 mg/dL), and hyperglycemia (>180 mg/dL) also can be observed.
11:52
Isolation of Basal Cells and Submucosal Gland Duct Cells from Mouse Trachea
0 Views •
Cited by 17 •
2012
Here we demonstrate our protocol for isolation of basal and submucosal gland duct cells from mouse tracheas. We also demonstrate the method of injecting stem cells into the dorsal mouse fat pad to create an in vivo model of submucosal gland regeneration.
05:51
Coculture Analysis of Extracellular Protein Interactions Affecting Insulin Secretion by Pancreatic Beta Cells
0 Views •
Cited by 3 •
2013
Transcellular protein interactions are important determinants of pancreatic beta-cell function. Detailed here is a method—adapted from a coculture model of synaptogenesis—for investigating how specific transmembrane proteins influence insulin secretion. Transfected HEK293 cells express proteins of interest; beta cells do not need to be transfected or otherwise directly perturbed.
08:45
Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts
0 Views •
Cited by 9 •
2016
Here, a new method that allows the conversion of adult skin fibroblasts into insulin-secreting cells is presented. This technique is based on epigenetic conversion, does not involve the use of retroviral vectors nor the acquisition of a stable pluripotent state. It is therefore highly promising for translational medicine applications.
FAQs
The insulin molecule and its formulation shape how quickly the preparation is absorbed and how long its activity persists. These properties determine the onset and duration of the background effect, which must extend between meals and overnight. Pharmacologic evaluation therefore considers both the active molecule and delivery formulation when assessing whether activity remains sufficiently continuous.
Maintaining insulin activity outside meal periods supports glucose uptake while suppressing hepatic glucose production. This background effect helps limit glucose increases that are unrelated to food intake, particularly overnight. If the activity is not appropriately matched to an individual’s needs, the intended glucose-lowering effect may be insufficient or may contribute to hypoglycemia.
Basal insulin supplies the background component of treatment, whereas bolus insulin addresses glucose rises associated with meals. Their complementary roles reflect different physiologic demands: one supports coverage between meals and overnight, while the other targets postprandial changes. This distinction allows pharmacologic regimens to combine sustained and meal-related insulin effects rather than relying on one pattern alone.
Selection depends on the preparation’s onset, duration, absorption characteristics, and dose, together with the desired pattern of glucose control. These factors influence whether insulin activity adequately covers the interval between meals and overnight. Clinicians and researchers also consider hypoglycemia risk, because the balance between sustained exposure and excessive activity is central to individualized therapy.
The background preparation is combined with mealtime insulin when treatment must address both ongoing glucose regulation and postprandial rises. Basal insulin covers the periods between meals and overnight, while bolus doses respond to meal-related increases. This combination reflects a pharmacologic strategy that matches different insulin requirements across the daily pattern of glucose control.
Basal insulin provides a framework for developing molecules and formulations with more suitable duration and absorption behavior. Pharmacology examines whether these characteristics can sustain insulin activity while reducing treatment limitations, including hypoglycemia risk. This research context links the desired clinical pattern, longer-lasting background coverage, with molecular and formulation changes intended to improve safety and consistency.